|Day Low/High||3.68 / 3.94|
|52 Wk Low/High||2.90 / 8.77|
CVS rival Walgreens thinks customers should be able to choose if they buy things that are 'bad' for them.
This deal looks likely to be wrapped up soon.
Here's what you need to know now.
A vote on the deal is likely to come this week, according to news outlet CTFN.
This deal looks like to be wrapped up soon.
Stocks mostly higher as indexes enter final week of first half.
Updates on Walgreens, Apple, Cisco and our energy positions.
Wall Street kicked off the final week of the first half of the year with a mixed end.
It's the final week of the second quarter and markets look to close out the past three months with solid gains.
The agency faces a July 7 deadline but the two sitting commissioners are expected to want the decision before the July 4 holiday.
Here's what the FTC is examining now.
We continue to believe in the story of these 3 companies, despite current weakness.
The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.
The FTC is concerned that the Walgreens and Rite Aid deal would result in higher drug prices for consumers.
Today, Rite Aid Corporation will celebrate the grand reopening of its Harrisburg Market Street store, now located at 304 Market Street, inside Strawberry Square.
If this is a bear market, why do the buyers keep showing up?
Tech rotation, oil and Fed rate hike keep markets on even (make that flat) keel. Several portfolio positions get beefed up.
Our takeaways and how we are thinking about the impact.
The added funds could ease regulators' doubts.
After a busy Thursday, markets look forward to economic data and the Fed meeting next week. In the portfolio, we dropped a tech stock and added a healthcare name.
A record close for the Nasdaq was looking likely until a swift selloff in tech dragged the index from its heights.
A record close for the Nasdaq was looking likely on Friday, June 9, until a swift and unexpected selloff in tech dragged the index from its heights.
The FTC has worried that Fred's can't replace the competition lost by elimination of Rite Aid from the drugstore scene.
A sudden, surprising selloff in technology names pulls the S&P 500 and Nasdaq from record intraday highs set earlier in the session.
The CEOs of Rite Aid and Walgreens issued memos to employees addressing delays and uncertainty from the FTC.
Rite Aid execs made it clear they are preparing the company to go it alone if the federal government blocks the deal.